This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG42027_L.jpg
The drugmaker said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity greater than 99.8% and can help assess patients’ immune response to the COVID-19 virus.
